-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Teva Pharmaceutical Industries Ltd annual Depreciation history and growth rate from 2010 to 2023.
- Teva Pharmaceutical Industries Ltd annual Depreciation for 2023 was $537M, a 6.77% decline from 2022.
- Teva Pharmaceutical Industries Ltd annual Depreciation for 2022 was $576M, a 9.09% increase from 2021.
- Teva Pharmaceutical Industries Ltd annual Depreciation for 2021 was $528M, a 1.68% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)